Locations:
Abu Dhabi|Canada|Florida|London|Nevada|Ohio|
Gray gradientGray gradient
Cleveland Clinic icon
Consult QD logo
Search IconSearch

Tag: asco18

PrimaryPulmonaryCarcinoid
June 5, 2018/Cancer/Research

Higher Blood-Based Tumor Burden Predicts Better Response to Immunotherapy in Metastatic NSCLC Patients

Results based on early data from clinical trial

nucleic-acid_650x450
June 4, 2018/Cancer/Research

CCGA Substudy Demonstrates Project’s Potential to Map Cancer Genetics

Early results presented at ASCO 2018

650×450-Renal-Cell-Carcinoma
June 3, 2018/Cancer/Research

IMmotion151 Reports Encouraging Results

New mRCC medication regimen effective and well tolerated

16-NEU-1934-Ahluwalia-650×450
June 2, 2018/Cancer/Research

Immunotherapy Vaccine Improves Survival Rates in Patients with Glioblastoma

Drug stimulates an immune response to survivin

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Metastatic melanoma cells. Image source: National Cancer Institute
June 2, 2018/Cancer/Research

Familial Melanoma Diagnosis Can Signal Higher Risk for Other Cancers

Many genetic alterations were related to other malignancies

breast cancer metastases
June 2, 2018/Cancer/Research

T-DM1 + Neratinib’s Safety and Efficacy in Women with Metastatic HER2+ Breast Cancer

Phase 1b trial shows good response rate

Brain research
June 1, 2018/Cancer/Research

ALLELE: Guiding Glioblastoma Treatment with Tumor Genetics

Individual tumor DNA may be key

BackPage 1 of 1Next

Advertisement

Ad